Unichem’s US arm recalls Buspirone tablets after stability test OOS result
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
The new assay consolidates screening for four major viral threats into a single workflow
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Subscribe To Our Newsletter & Stay Updated